News on Urology continually updated from thousands of sources around the net.
23 hrs ago | Temple City Tribune
Testosterone replacement therapy suits everyone we typically rate an endothelial Cialis Online Cialis Online disease or simply hardening of wall street.
What's the best route to energy independence?
Do You Know the NRA?
Monday | EurekAlert!
With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists, according to UC Davis prostate cancer experts.
Monday | Freshnews
BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, at 12 months following the U.S. launch of Medivation/Astellas Pharma's Xtandi for docetaxel-pretreated metastatic castrate-resistant prostate cancer , the majority of surveyed oncologists stated that they have ... (more)
Monday | Live Science
Inflammation in a man's prostate may indicate he has a lower risk of developing prostate cancer in the future, according to a new study.
Of all the newly diagnosed bladder cancer patients, 25%-30% of them will have muscle-invasive disease that ideally will require major surgery in the form of a radical cystectomy, bilateral pelvic lymphadenectomy and creation of a urinary diversion as an integral part of curative therapy.
Auxilium Pharmaceuticals, Inc . , a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX , an in-office, biologic for the treatment of Peyronie's disease .
Although the demand for infertility treatment is rising, the high cost may deter some couples from seeking care.
In November, the men of the Today show stopped shaving to raise awareness for men's health, specifically testicular and prostate cancer.
Editor at Cancer Gene Therapy Week -- Research findings on Bio technology are discussed in a new report.
The French President was hospitalised for 'several days' in France 2011, but the procedure has been kept secret until now.
Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer’ 1Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs ... (more)
CDRD Ventures Inc. , the commercialization vehicle of The Centre for Drug Research and Development , announced today the launch of a new spin-off company, Sitka Biopharma Inc., a biotechnology company developing a new bladder cancer treatment.
Brad Lerner, MD, is a urologist, physician owner and medical director at Summit Ambulatory Surgical Centers, a group of 15 Urology ASCs in Maryland that performed more than 20,000 procedures last year.